Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology  |  Family Medicine  |  Sleep

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Insomnia Clinical Trials

A listing of Insomnia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (121) clinical trials

Outpatient study designed to test a new investigational medication in adults 50 years and older with insomnia. Compensation is $1450. To qualify, you must be 50 years and older. Length of study: 4-6 weeks Overnight visits: 5 Total number of outpatient visits: 6 For more information,

Phase N/A

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia. To qualify, you must be: 18 years and older Length of study: 6 weeks Overnight visits: 10 Total number of outpatient visits: 1 For more information,

Phase N/A

The study aims to understand the effectiveness of a six-week course of light exposure on cognitive functioning, mood, activity, and sleep in people that have suffered a mild traumatic brain injury (mTBI) or "concussion." The entire study lasts 13 weeks with only 4 visits to Banner UMC and includes six ...

Phase N/A

The purpose of this study is to see if the study drug, suvorexant, is safe and effective in treating symptoms of insomnia in people with Parkinson's Disease. It is anticipated that a total of 20 subjects, 30 to 80 years of age, with Parkinson's Disease and symptoms of insomnia will ...

Phase

If you are having trouble staying asleep almost every night, you may qualify for a research study of an investigational sleep medication. If you are 18 years of age or older And not able to sleep through the night 4 or more times a week Please call Commonwealth Clinical Research ...

Phase N/A

This is a study to test the safety and tolerability of the research study drug, suvorexant and test the effects of suvorexant compared to placebo in improving insomnia in subjects with mild to moderate Alzheimer’s disease.

Phase

  The purpose of this research study is to assess the safety and tolerability of an investigational medication foe insomnia compared with zolpidem and placebo in subjects with insomnia disorder. This study is comprised of 2 office visits, 6 overnight stays, and one phone call over approximately 2 months. The ...

Phase

The purpose of this research study is to examine the safety and efficacy of an investigational medication for adult subjects that have trouble falling asleep and staying asleep.

Phase N/A

Effects of Group Cognitive Behavioural Therapy on Comorbid Insomnia and Depression in Youth

Major depressive disorder (MDD) is among the most common psychiatric disorders among adolescents, and is associated with considerable psychosocial and functional impairments and an elevated risk of suicidal behaviour and completed suicide. Meanwhile, sleep disturbance, particularly insomnia, is among the most prevalent and prominent presenting complaints in adolescents with depression. ...

Phase N/A

New Clinical Applications for Internet-based Cognitive Behavior Therapy for Insomnia and Depression

This study includes two sub-trials. Both are included in this singe registration since they have parallel inclusion of participants and have been approved by the Swedish ethics board together in one application. Trial 1 includes patients with both insomnia and major or minor depression. Participants are randomized to either a ...

Phase N/A